Wave Life Sciences to Join NYC Healthcare Panel
CEO Paul Bolno will speak at Chardan's 10th Annual Healthcare Conference on October 20, 2026.
Updated on Oct. 13, 2026 in Biotech
Wave Life Sciences President and CEO Paul Bolno will participate in a panel discussion at Chardan's 10th Annual Healthcare Conference in New York City on October 20, 2026. The biotech executive is scheduled to speak at 9:45 a.m. ET.
Why it matters
The appearance highlights Wave Life Sciences' position within the clinical-stage biotechnology sector as it engages with industry peers and stakeholders. The company focuses on the development of next-generation RNA therapeutics.
The conference features the 10th annual gathering of healthcare industry leaders to discuss emerging medical technologies. The scheduled panel, titled RNA Medicines: Next-Generation RNA Therapeutics, will take place at 9:45 a.m. ET.
The players
Paul Bolno
Paul Bolno serves as the President and Chief Executive Officer of the clinical-stage biotechnology firm Wave Life Sciences.
Wave Life Sciences
Wave Life Sciences is a biotechnology company headquartered in Cambridge, Mass., dedicated to clinical-stage research.
The details
The panel will center on the advancement of RNA-based medicines and emerging therapeutic applications in the biotechnology field. A live webcast of the session will be available for remote access through the company's investor relations portal.
Timeline
Paul Bolno participates in the panel on October 20, 2026, at 9:45 a.m. ET.
The Tech Race
The company's focus on next-generation RNA therapeutics represents a significant shift from traditional small-molecule drugs toward precise genetic modulation. This event underscores the competitive race among biotech firms to establish dominance in the evolving RNA medicine landscape.
Investors and industry observers can access the live webcast through the official investor relations portal to stay updated on the company's research progress. This access allows the public to monitor the firm's strategic direction and therapeutic developments in real time.
The takeaway
Public conference participation serves as a key indicator for investors tracking the advancement of biotech clinical pipelines. Interested parties should utilize official company webcasts to ensure they are receiving verified information directly from corporate leadership.
Further reading
For more on the latest research in the field, see the latest developments in Biotech.
More information
The full session details are available on the Wave Life Sciences investor events portal.
Source note: This article includes information reported by The Manila times.
